16 related results for spaf

Things to consider when aiming to prevent stroke in a patient with AF

EPCCS 2017 Prof. David Fitzmaurice and dr. Geert-Jan Geersing consider the updates in the latest ESC Guidelines on atrial fibrillation that are most relevant to GPs, including which risk scores can help to optimally manage AF, and which drawbacks the scores have.

Doubled risk of acute MI in real world AF patients receiving DOACs or aspirin vs. VKA

Literature 11-4-2017 • Stolk LM et al., Br J Clin P harmacol 2017
Analysis of new users of rivaroxaban or dabigatran, aspirin and VKAs in CPRD reveals a two-fold increased risk of AMI in current users of DOAC or aspirin, as compared with VKA.

EPCCS Guidance Documents

Meeting report Evidence- and meeting-based guidance for primary care

EPCCS consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care

News 6-9-2016
General practitioners representing various European countries discussed recent developments in the SPAF field, and specific implications for primary care in an expert meeting. This meeting resulted in a practical guidance for European GPs.

Real-world safety data show differences between anticoagulants in AF patients

Literature 23-8-2016 • Lip GYH et al., Thromb Haemost 2016
In a real-world observational study using propensity score matched cohorts, apixaban initiation was associated with significantly lower risk of major bleeding compared to warfarin and rivaroxaban.

Many AF patients inappropriately on aspirin monotherapy rather than on anticoagulation

Literature 1-7-2016 • Hsu JH et al., J Am Coll Cardiol 2016
Approximately one third of AF outpatients at moderate to high risk for stroke treated by a cardiovascular specialist, received aspirin monotherapy, in spite of the lack of data supporting this practice.

EPCCS well represented at WONCA congress

News 28-6-2016
Representatives of the EPCCS board organised three well-attended sessions at WONCA Europe 2016 in Copenhagen, Denmark, covering topics ranging from heart failure to the pros and cons of statins.

EHRA practical guide for non-vitamin K antagonist anticoagulants in non-valvular AF patients updated

News 15-6-2016
The European Heart Rhythm Association (EHRA) published a rewritten, updated version of the previously published (2013) guidelines for NOACs in non-valvular AF patients.

Adherence to oral anticoagulation affects outcomes in AF patients at high stroke risk

Literature 29-2-2016 • Yao et al., J Am Heart Assoc. 2016
In patients with atrial fibrillation, adherence to oral anticoagulation for stroke prevention was modestly improved by the use of NOACs, which impacts mainly the outcomes of high-risk patients.

German AFNET and EHRA lay out roadmap to improve AF management

News 19-10-2015
Many people have undiagnosed and therefore untreated AF, associated with high risk of strokes and death. AFNET and EHRA composed recommendations aimed to improve AF diagnosis and treatment.

Online Learning - EPCCS SPAF Consensus Document

News 6-8-2015
PeerVoice Education developed a learning activity about the EPCCS SPAF Consensus Document: "Expert Insights on EPCCS Recommendations for Stroke Prevention in Atrial Fibrillation: What General Practitioners Need to Know".

Stroke detection and prevention in atrial fibrillation

Literature 23-7-2015 • Prof. Richard Hobbs - Br. J. Gen. Prac. 2015
Professor Richard Hobbs, Chairman of EPCCS Scientific Organising Committee, wrote an editorial in the July issue of Br J Gen Prac, in which three articles on stroke and its better prevention are published.

​Stroke prevention in atrial fibrillation

Webcast Amsterdam
Four European Primary Care experts, prof. Richard Hobbs, prof. David Fitzmaurice, Clare Taylor MD and Frans Rutten MD, summarise a fascinating discussion at the stroke prevention in atrial fibrillation expert meeting.

The EPCCS Stroke Prevention in Atrial Fibrillation Guidance Document

Webcast EPCCS 2014, Brussels
Prof. David Fitzmaurice (Birminham, United Kingdom) gives a preview of what will be covered in the EPCCS Stroke Prevention in Atrial Fibrillation Guidance Document, which has been composed by an EPCCS Working Group on the subject. The manuscript has been accepted for publication


Update 13-10-2014
During the Cardiovascular Disease Clinical Master Class 2014 in Brussels, one session was dedicated to a Clinical Updates on diabetes, hypertension and SPAF.

The NOACs in SPAF: primary care and beyond

E-Learning EPCCS, September 5-6, 2013
John Eikelboom MD (Ontario, Canada) discusses the evidence supporting guideline recommendations for the use of new oral anticoagulants (NOACs) to prevent stroke in atrial fibrillation (SPAF). 

Upcoming meetings

EPCCS Council Meeting December 6-7, 2017, Stratford Upon Avon, United Kingdom
10th EPCCS Annual CV Summit for Primary care March 15-16, 2018, Malaga, Spain
All upcoming meetings...

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...